15.05.2017 12:18:00

Sapiens Reports Q1 2017 Financial Results

HOLON, Israel, May 15, 2017 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the first quarter ended March 31, 2017.

First Quarter Highlights:

  • GAAP and non-GAAP revenue of $56.5 million, up 14.1% compared to $49.6 million in the first quarter of 2016.
  • GAAP operating loss totaled $(1.6 million), compared to operating income of $6.2 million in the first quarter of 2016.
  • Non-GAAP operating profit totaled $1.7 million (3.0% operating margin), compared to $7.3 million (14.8% operating margin) in the first quarter of 2016.
  • GAAP net loss attributable to Sapiens' shareholders totaled $(2.2 million) or $(0.05) per diluted share, compared to net income attributable to Sapiens' shareholders of $4.9 million, or $0.10 per diluted share in the first quarter last year.
  • Non-GAAP net income attributable to Sapiens' shareholders totaled $1.2 or $0.02 per diluted share, compared to net income attributable to Sapiens' shareholders of $6.0 million, or $0.12 per diluted share, in the first quarter last year.
  • Cash and cash equivalents as of March 31, 2017 were $35.1 million. This amount is post cash payment for the $100 million acquisition of StoneRiver, Inc. in the first quarter. Sapiens also raised $40 million in new bank debt during the first quarter to finance the remainder of the StoneRiver acquisition and working capital.

"Sapiens delivered another quarter of double-digit revenue increase, driven by a mix of organic growth and our recent acquisition of StoneRiver," said Roni Al-Dor, president and CEO of Sapiens. Two factors are offseting this growth to some extent in the near term, particularly in terms of operational profitability: the halt of a software development project with a significant customer and the integration of StoneRiver. In the second quarter, we will continue restructuring steps to address these developments and remain on track in the second half of 2017."

Al-Dor continued, "We are very excited about the closing of the StoneRiver acquisition towards the end of the first quarter. It significantly expanded our presence and scale in the North American insurance market and accelerated our entry into the U.S. P&C and L&A spaces. We have already gained a new customer via our new StoneRiver offerings and another StoneRiver customer is now in production."

Sapiens won new customers and continued to expand its business with existing customers during the first quarter. Alexander Forbes, a pan-African financial services group, selected the full Sapiens' portfolio. Sapiens' core systems will provide end-to-end, integrated digital capabilities across all lines of business and Sapiens will serve as the primary implementation partner. Additionally, Sapiens was selected shortly after the conclusion of the first quarter by a leading Nordic insurer for a modernization project worth over $30 million. This strategic new customer selected a wide range of Sapiens' P&C and reinsurance solutions to modernize its environment.

"Sapiens has a strategy in place to improve our cost structure and return to double-digit operating margins in the second half of 2017, and we believe we are currently on track with our plan," said Roni Al-Dor, president and CEO. "We are currently implementing a restructuring and reorganization program that includes integrating Sapiens' and StoneRiver's back-office operations to reduce expenses, maximizing synergies between our respective delivery teams and combining our R&D efforts to better utilize previously developed assets."

"Our plan also includes realigning and shifting employees away from the halted project and downsizing as necessary," concluded Al-Dor.

Sapiens maintains its recently revised guidance for 2017 full year revenues of $265 to $275 million (on a non-GAAP basis) and maintains expectations for between 3-4% operating profit margin for the first half of 2017, increasing to 13.5-14.5% in the second half of the year (in each case, on a non-GAAP basis). Sapiens also maintains expectations for a full-year operating profit margin between 9-10% (on a non-GAAP basis).

Quarterly Results Conference Call

Management will host a conference call and webcast on May 15 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-668-9141; International: +972-3-918-0685; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until May 22, 2017, as follows:

North America: 1-877-456-0009; International: +972-3-925-5940

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition, acquisition-related costs, restructuring and reorganizational costs, loss on sales of Marketable Securities and tax adjustment re non-GAAP adjustments.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition, acquisition-related costs, restructuring and reorganizational costs,  financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 400 financial services organizations. The Sapiens team of approximately 2,500 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2016, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

Investors and Media Contact:
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
US Mobile: +1-201-250-9414
Mobile: +972-54-9099039
Email: yaffa.cohen-ifrah@sapiens.com

               

              

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)





  Three months ended




 March 31,




2017


2016




 (unaudited)


 (unaudited)







 Revenue


56,534


49,567

 Cost of revenue


37,388


29,607







 Gross profit


19,146


19,960







 Operating Expenses:






 Research and development, net


6,195


3,253


 Selling, marketing, general and administrative


14,588


10,456

 Total operating expenses


20,783


13,709







 Operating income (loss)


(1,637)


6,251







 Financial expense (income), net


438


(80)

 Taxes and other expenses, net


167


1,458













 Net income


(2,242)


4,873







 Attributable to non-controlling interest


(30)


(14)







 Net income attributable to Sapiens' shareholders


(2,212)


4,887













 Basic earnings per share


(0.05)


0.10







 Diluted earnings per share


(0.05)


0.10







Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)


49,047


48,819






Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)


49,047


49,560


 

 

Summary of Non-GAAP Financial Information

 U.S. dollars in thousands (except per share amounts)



Three months ended


March 31,


2017


2016


(unaudited)


(unaudited)







Revenues

56,534

100%


49,567

100%

Gross Profit

20,470

36.2%


21,574

43.5%

Operating profit

1,698

3.0%


7,348

14.8%

Net income to shareholders

1,184

2.1%


5,986

12.1%

Adjusted EBITDA

2,574

4.6%


7,955

16.0%







Basic earnings per share

0.02



0.12


Diluted earnings per share

0.02



0.12


 

 

 

Non-GAAP revenues by geographic breakdown

U.S. dollars in thousands



Q1 2017


Q4 2016


Q3 2016


Q2 2016


Q1 2016











North America

19,465


21,107


19,706


17,601


16,041

Europe & South Africa

32,489


28,292


28,675


26,124


28,421

APAC

4,580


7,714


8,099


9,305


5,105











Total

56,534


57,113


56,480


53,030


49,567


 

 

 

Adjusted EBITDA Calculation

U.S. dollars in thousands




Three months ended



 March 31,



2017


2016






GAAP operating profit


(1,637)


6,251






Non GAAP adjustments:





Amortization of capitalized software


1,021


1,409

Amortization of other intangible assets


1,254


511

Capitalization of software development


(1,065)


(1,384)

Stock-based compensation


455


458

Compensation related to acquisition and acquisition related costs


1,670


103






Non GAAP operating profit


1,698


7,348






Depreciation


876


607






Adjusted EBITDA


2,574


7,955


 

 

 


SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)




  Three months ended



 March 31,



2017


2016

 GAAP revenue


56,534


49,567

 Adjustments of pre-acquisition revenue accounted under pooling of interest method


-



 Non-GAAP revenue


56,534


49,567











 GAAP gross profit


19,146


19,960

 Amortization of capitalized software


1,021


1,409

 Amortization of other intangible assets


303


205

 Non-GAAP gross profit


20,470


21,574











 GAAP operating income


(1,637)


6,251

 Gross profit adjustments


1,324


1,614

 Capitalization of software development


(1,065)


(1,384)

 Amortization of other intangible assets


951


306

Stock-based compensation


455


458

Compensation related to acquisition and acquisition related costs


1,670


103

 Non-GAAP operating income


1,698


7,348











 GAAP net income attributable to Sapiens' shareholders


(2,212)


4,887

 Operating income adjustments


3,335


1,097

 Adjustment to redeemable non-controlling interest




66

Loss on sales of marketable securities


230



 Other


(169)


(64)

 Non-GAAP net income attributable to Sapiens' shareholders


1,184


5,986











 Non-GAAP basic earnings per share 


0.02


0.12






 Non-GAAP diluted earnings per share


0.02


0.12











Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

49,047


48,819

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

49,998


49,560

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands










March 31,


December 31,



2017


2016




 (unaudited)


 (unaudited)







 ASSETS












 CURRENT ASSETS:






Cash and cash equivalents


35,115


60,908


Trade receivables, net


52,837


34,684


Other receivables and prepaid expenses


8,036


6,389


Marketable securities


-


18,220








 Total current assets


95,988


120,201







 LONG-TERM ASSETS:






Marketable securities


-


17,228


Property and equipment, net


10,945


9,807


Severance pay fund


4,205


4,041


Goodwill and intangible assets, net


225,845


101,951


Other long-term assets


4,091


4,623








 Total long-term assets


245,086


137,650







 TOTAL ASSETS


341,074


257,851







LIABILITIES AND EQUITY











 CURRENT LIABILITIES:






 Trade payables


7,136


6,562


 Accrued expenses and other liabilities


44,024


32,049


 Deferred revenue


18,729


9,137


Current Maturities of Long Term Loans


8,000


-


Total current liabilities


77,889


47,748







 LONG-TERM LIABILITIES:






 Other long-term liabilities


26,679


9,864


Long Term Loans


32,000


-


 Accrued severance pay


5,106


4,940








 Total long-term liabilities


63,785


14,804













REDEEMABLE NON-CONTROLLING INTEREST


908


908







 EQUITY



198,492


194,391







 TOTAL LIABILITIES AND EQUITY


341,074


257,851

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands



For the three months ended

March 31,


2017

2016


(unaudited)

(unaudited)

Cash flows from operating activities:



Net income (loss)

(2,242)

4,873

Reconciliation of net income to net cash provided by operating activities:



Depreciation and amortization

3,151

2,527

Amortization of premium, and accrued interest and loss on sales of
marketable securities

509

(134)

Stock-based compensation related to options issued to employees

455

458




Net changes in operating assets and liabilities, net of amount acquired:



Trade receivables

(10,510)

(6,682)

Deferred tax assets

(1,009)

107

Other operating assets

681

(227)

Trade payables

(771)

419

Other operating liabilities

908

98

Deferred revenues

1,556

3,052

Severance pay

(49)

(34)




Net cash provided by operating activities

(7,321)

4,457




Cash flows from investing activities:



Purchase of property and equipment

(580)

(849)

Purchase of marketable securities, net of interest received

-

99

Proceeds from sales of marketable securities

35,369

-

Payments for business acquisition, net of cash acquired

(94,111)

-

Capitalized software development costs

(1,065)

(1,384)

Restricted cash

-

(2)




Net cash used in investing activities

(60,387)

(2,136)




Cash flows from financing activities:



Proceeds from employee stock options exercised

110

473

Loan received net of Repayment of loan

39,987

-




Net cash used in financing activities

40,097

473




Effect of exchange rate changes on cash and cash equivalents

1,818

1,534




Increase in cash and cash equivalents

(25,793)

4,328

Cash and cash equivalents at the beginning of period

60,908

54,351




Cash and cash equivalents at the end of period

35,115

58,679

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sapiens-reports-q1-2017-financial-results-300457361.html

SOURCE Sapiens International Corporation

Nachrichten zu Sapiens International Corporation NVShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Sapiens International Corporation NVShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Formula Systems 82,50 2,48% Formula Systems